The SEC stated: "From April 1997 through August 2000 (the "Relevant Period"), Pediatrix intentionally backdated stock option grants, creating approximately $8,8 million in compensation expense under Generally Accepted Accounting Principles C'GAAP"). However, the Company did not originally record the expense, causing the financial statements Pediatrix filed with the Commission, with respect to the Relevant Period, to materially understate its expenses and overstate its pre-tax income by a total of 6.74 percent."

The SEC stated that: "[It] charged Pediatrix Medical Group, Inc. (now known as Mednax Services, Inc.) with backdating stock options grants to executives and employees and with reporting false financial information to shareholders. Pediatrix Medical Group, Inc. ("Pediatrix"), is a physician services provider headquartered in Sunrise, Florida. The Commission's complaint alleges that from approximately 1997 through 2000, Pediatrix, by the actions of a now-deceased former senior financial officer, granted options at below-market prices ("in-the-money" options). Pediatrix has agreed to settle the Commission's charges without admitting or denying the allegations."

On March 6, 2009, the Court issued a final judgment as to Defendant Pediatrix Medical Group, Inc., stating: "Defendant Pediatrix Medical Group, Inc., now known as Mednax Services, Inc. . . . entered a general appearance; consented to the Court=s jurisdiction over it and the subject matter of this action; consented to entry of this Final Judgment without admitting or denying the allegations of the Complaint (except as to jurisdiction); waived findings of fact and conclusions of law; and waived any right to appeal from this Final Judgment."